Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Research (NRC) EBIT (2016 - 2025)

National Research (NRC) has disclosed EBIT for 16 consecutive years, with -$14.2 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 24.37% to -$14.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, down 45.4% year-over-year, with the annual reading at $3.7 million for FY2025, 45.42% down from the prior year.
  • EBIT hit -$14.2 million in Q4 2025 for National Research, down from $7.7 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $13.1 million in Q3 2021 to a low of -$19.9 million in Q4 2023.
  • Historically, EBIT has averaged $5.8 million across 5 years, with a median of $9.2 million in 2023.
  • Biggest five-year swings in EBIT: soared 31.96% in 2021 and later crashed 262.91% in 2023.
  • Year by year, EBIT stood at $12.9 million in 2021, then fell by 4.91% to $12.2 million in 2022, then plummeted by 262.91% to -$19.9 million in 2023, then increased by 6.03% to -$18.7 million in 2024, then increased by 24.37% to -$14.2 million in 2025.
  • Business Quant data shows EBIT for NRC at -$14.2 million in Q4 2025, $7.7 million in Q3 2025, and $1.6 million in Q2 2025.